Dr. Jason N. Valent, MD

Dr. Valent practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Valent's NPI, 1013936871, was assigned on July 19, 2006. Dr. Valent graduated from University of Cincinnati College of Medicine in 2002. Dr. Valent holds Ohio license 35.085833.

Dr. Valent's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Valent's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Valent is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Valent to 3 more hospitals, 2 clinical labs and 1 group practice or clinic, each named with a free account. Dr. Valent's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valent practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Valent's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Valent is licensed in Ohio.

CMS data shows 1,134 Medicare services from Dr. Valent across 9 procedure codes in 2024, for 295 Medicare patients. Medicare paid $63,188 for them.

CMS counts 295 Medicare patients who saw Dr. Valent in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valent's median patient age at 70, with 46% women.

In 2024, Dr. Valent wrote 2,621 Medicare Part D claims for 234 patients. 73% of them were for generic drugs. CMS names the drug for 2,284 of them, across 51 drugs with 11 or more claims each, at $12,336,224 in total drug cost. In 2023, CMS named 2,091 claims across 53 drugs.

Dr. Valent accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Valent as offering telehealth.

Dmand AI links 58 papers to Dr. Valent, published from 2012 to 2024. 2023 was the busiest year, with 9. The most frequent topics are Multiple Myeloma, Amyloidosis and Antineoplastic Agents. Dr. Valent has published most often in Br J Haematol. Dr. Valent's most frequent co-authors are Christy Joy Samaras, DO, Faiz Anwer, MD and Sandra Mazzoni, DO.

Dmand AI links Dr. Valent to 6 clinical trials, 3 of them phase 2 studies. Conditions studied include Immunoglobulin Light-chain Amyloidosis, Amyloidosis and Multiple Myeloma. Prothena Biosciences Ltd. sponsors the most, 3.

CMS Open Payments shows 66 general payments to Dr. Valent from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 89% of the total. Celgene Corporation paid the most, $24,937.

Dr. Valent graduated from University of Cincinnati College of Medicine in 2002.